Panel discussion on the treatment of patients with factor VIII inhibitors.
D000818:Animals; D000906:Antibodies; D003520:Cyclophosphamide / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005169:Factor VIII / Q000276:immunology* / Q000627:therapeutic use; D006395:Hemarthrosis / Q000628:therapy*; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans; D013552:Swine
D000906:Antibodies; D003520:Cyclophosphamide; D005169:Factor VIII